BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 21570253)

  • 1. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
    Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
    Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation.
    Kefer J; Beauloye C; Astarci P; Renkin J; Glineur D; Dekleermaeker A; Vanoverschelde JL
    Am J Cardiol; 2010 Dec; 106(12):1782-6. PubMed ID: 21055712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
    Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
    Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
    Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
    Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
    López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
    Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
    Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
    J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.
    Lim P; Monin JL; Monchi M; Garot J; Pasquet A; Hittinger L; Vanoverschelde JL; Carayon A; Gueret P
    Eur Heart J; 2004 Nov; 25(22):2048-53. PubMed ID: 15541842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis.
    Weber M; Hausen M; Arnold R; Nef H; Moellman H; Berkowitsch A; Elsaesser A; Brandt R; Mitrovic V; Hamm C
    Heart; 2006 Nov; 92(11):1639-44. PubMed ID: 16740919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
    Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
    J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
    Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study.
    Bergler-Klein J; Mundigler G; Pibarot P; Burwash IG; Dumesnil JG; Blais C; Fuchs C; Mohty D; Beanlands RS; Hachicha Z; Walter-Publig N; Rader F; Baumgartner H
    Circulation; 2007 Jun; 115(22):2848-55. PubMed ID: 17515464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D
    Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.
    Rabus MB; Kirali K; Kayalar N; Tuncer EY; Toker ME; Yakut C
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):41-6. PubMed ID: 19196573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.